[1] |
Qi M, Kinzer K, Danielson KK, et al. Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience[J]. Acta Diabetol, 2014, 51(5):833-843.
|
[2] |
Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes[J]. Lancet, 2014, 383(9911):69-82.
|
[3] |
Choudhary P, Geddes J, Freeman JV, et al. Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring[J]. Diabet Med, 2010, 27(6): 666-672.
|
[4] |
Hering BJ, Clarke WR, Bridges ND, et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia[J]. Diabetes Care, 2016, 39(7):1230-1240.
|
[5] |
陈焕伟,栾晓军,刘成洋, 等. 同种异体胰岛细胞移植在成人1型糖尿病中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(5):457-461.
|
[6] |
Ballou C, Brindley H, Guan E, et al. Tenth annual report[EB/OL].
URL
|
[7] |
Lablanche S, Vantyghem MC, Kessler L, et al. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial[J]. Lancet Diabetes Endocrinol, 2018, 6(7): 527-537.
|
[8] |
王树森,崔云峰,王西墨. 慢性胰腺炎全胰切除联合自体胰岛移植指南解读[J/CD]. 实用器官移植电子杂志, 2016, 4(6):321-326.
|
[9] |
Witkowski P, Savari O, Matthews JB. Islet autotransplantation and total pancreatectomy[J]. Adv Surg, 2014(48):223-233.
|
[10] |
Shindo Y, Kanak MA. Total pancreatectomy with islet autotransplantation: recent updates and outcomes[J]. Curr Opin Organ Transplant, 2017, 22(5):444-451.
|
[11] |
陈焕伟,栾晓军,刘成洋, 等. 全胰腺切除联合自体胰岛移植治疗慢性胰腺炎1例报道并文献复习[J]. 器官移植, 2018, 9(6): 451-455.
|
[12] |
Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen[J]. N Engl J Med, 2000, 343(4):230-238.
|
[13] |
Bellin MD, Barton FB, Heitman A, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes[J]. Am J Transplant, 2012, 12(6): 1576-1583.
|
[14] |
Shapiro AM. State of the art of clinical islet transplantation and novel protocols of immunosuppression[J]. Curr Diab Rep, 2011, 11(5): 345-354.
|
[15] |
Williams J, Jacus N, Kavalackal K, et al. Over ten-year insulin independence following single allogeneic islet transplant without T-cell depleting antibody induction[J]. Islets, 2018, 10(4):168-174.
|
[16] |
Posselt AM, Szot GL, Frassetto LA, et al. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade[J]. Transplantation, 2010, 90(12):1595-1601.
|
[17] |
Posselt AM, Bellin MD, Tavakol M, et al. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab[J]. Am J Transplant, 2010, 10(8):1870-1880.
|
[18] |
El Khatib MM, Sakuma T, Tonne JM, et al. β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection[J]. Gene Ther, 2015, 22(5):430-438.
|
[19] |
Watanabe M, Yamashita K, Suzuki T, et al. ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates[J]. Am J Transplant, 2013, 13(8): 1976-1988.
|
[20] |
Citro A, Cantarelli E, Maffi P, et al. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation[J]. J Clin Invest, 2012, 122(10):3647-3651.
|
[21] |
Kandaswamy R, Skeans MA, Gustafson SK, et al. OPTN/SRTR 2013 annual data report: pancreas[J]. Am J Transplant, 2015, 15 Suppl 2: 1-20.
|
[22] |
Grose S. Critics slam Russian trial to test pig pancreas for diabetics[J]. Nat Med, 2007, 13(4):390-391.
|
[23] |
王维,莫朝辉,叶斌, 等. 新生猪胰岛移植治疗糖尿病病人的临床研究[J]. 中南大学学报(医学版), 2011, 36(12):1134-1140.
|
[24] |
Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation[J]. Lancet, 2005, 365(9471):1642-1644.
|
[25] |
Jung HS, Choi SH, Kim SJ, et al. A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors[J]. Clin Transplant, 2007, 21(6):738-743.
|
[26] |
Hirshberg B. Can we justify living donor islet transplantation?[J]. Curr Diab Rep, 2006, 6(4):307-309.
|
[27] |
Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes[J]. JAMA, 2005, 293(7):830-835.
|
[28] |
Koh A, Senior P, Salam A, et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success[J]. Transplantation, 2010, 89(4): 465-471.
|
[29] |
Shapiro AM. Strategies toward single-donor islets of Langerhans transplantation[J]. Curr Opin Organ Transplant, 2011, 16(6):627-631.
|
[30] |
McCall MD, Toso C, Baetge EE, et al. Are stem cells a cure for diabetes?[J]. Clin Sci, 2009, 118(2):87-97.
|
[31] |
Liu X, Li X, Zhang N, et al. Bioengineering strategies for the treatment of type I diabetes[J]. J Biomed Nanotechnol, 2016, 12(4): 581-601.
|
[32] |
Hrvatin S, O'Donnell CW, Deng F, et al. Differentiated human stem cells resemble fetal, not adult, β cells[J]. Proc Natl Acad Sci U S A, 2014, 111(8):3038-3043.
|
[33] |
Rekittke NE, Ang M, Rawat D, et al. Regenerative therapy of type 1 diabetes mellitus: from pancreatic islet transplantation to mesenchymal stem cells[J]. Stem Cells Int, 2016:3764681.
|
[34] |
Pathak V, Pathak NM, O'Neill CL, et al. Therapies for type 1 diabetes: current scenario and future perspectives[J]. Clin Med Insights Endocrinol Diabetes, 2019(12):117955141984452.
|
[35] |
Potter KJ, Westwell-Roper CY, Klimek-Abercrombie AM, et al. Death and dysfunction of transplanted beta-cells: lessons learned from type 2 diabetes?[J]. Diabetes, 2014, 63(1):12-19.
|
[36] |
Cheng Y, Wang B, Li H, et al. Mechanism for the instant blood-mediated inflammatory reaction in rat islet transplantation[J]. Transplant Proc, 2017, 49(6):1440-1443.
|
[37] |
Samy KP, Davis RP, Gao Q, et al. Early barriers to neonatal porcine islet engraftment in a dual transplant model[J]. Am J Transplant, 2018, 18(4):998-1006.
|
[38] |
Shapiro AM. Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome[J]. Rev Diabet Stud, 2012, 9(4):385-406.
|
[39] |
Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis[J]. J Am Coll Surg, 2012, 214(4):409-424.
|
[40] |
Kanak MA, Takita M, Shahbazov R, et al. Evaluation of microRNA375 as a novel biomarker for graft damage in clinical islet transplantation[J]. Transplantation, 2015, 99(8):1568-1573.
|
[41] |
Yoshimatsu G, Takita M, Kanak MA, et al. MiR-375 and miR-200c as predictive biomarkers of islet isolation and transplantation in total pancreatectomy with islet autotransplantation[J]. J Hepatobiliary Pancreat Sci, 2016, 23(9):585-594.
|
[42] |
Bellin MD, Clark P, Usmani-Brown S, et al. Unmethylated insulin DNA is elevated after total pancreatectomy with islet autotransplantation: assessment of a novel beta cell marker[J]. Am J Transplant, 2017, 17(4):1112-1118.
|
[43] |
Marselli L, Thorne J, Ahn YB, et al. Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection[J]. J Clin Endocrinol Metab, 2008, 93(3):1046-1053.
|
[44] |
Morgan KA, Lancaster WP, Owczarski SM, et al. Patient selection for total pancreatectomy with islet autotransplantation in the surgical management of chronic pancreatitis[J]. J Am Coll Surg, 2018, 226(4):446-451.
|
[45] |
Wang J, Sun Z, Gou W, et al. α-1 antitrypsin enhances islet engraftment by suppression of instant blood-mediated inflammatory reaction[J]. Diabetes, 2017, 66(4):970-980.
|
[46] |
Citro A, Cantarelli E, Maffi P, et al. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation[J]. J Clin Invest, 2012, 122(10):3647-3651.
|
[47] |
McCall MD, Maciver AM, Kin T, et al. Caspase inhibitor IDN6556 facilitates marginal mass islet engraftment in a porcine islet autotransplant model[J]. Transplantation, 2012, 94(1):30-35.
|